Is switching from letrozole to tamoxifen due to osteoporosis a common consideration?
Yes, switching from letrozole to tamoxifen because of osteoporosis is a valid option to discuss with your oncologist. Letrozole and other aromatase inhibitors can cause bone thinning, with nearly 11 percent of women developing osteoporosis Show Full Answer
Is switching from letrozole to tamoxifen due to osteoporosis a common consideration?
Yes, switching from letrozole to tamoxifen because of osteoporosis is a valid option to discuss with your oncologist. Letrozole and other aromatase inhibitors can cause bone thinning, with nearly 11 percent of women developing osteoporosis while taking letrozole.
Tamoxifen works differently than letrozole. While it blocks estrogen in breast tissue, it doesn't lower estrogen levels throughout your body the same way aromatase inhibitors do. This means tamoxifen may have less impact on bone density.
However, tamoxifen comes with its own set of potential side effects, including:
- Hot flashes and night sweats
- Joint pain
- Fatigue
- Vaginal dryness
- Mood changes
- Weight gain or swelling
- Increased risk of blood clots, stroke, and uterine cancer (rare but serious)
Your doctor will need to weigh the benefits and risks of switching medications. They'll consider your bone density, fracture risk, overall health, and how well tamoxifen might work for your specific type of breast cancer.
Don't stop taking letrozole on your own. Talk with your cancer care team about whether switching is right for you, as stopping hormone therapy early can increase the risk of cancer recurrence.
January 9
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
